Evidence map›Paper›PMID 29084415›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2017

Association of Distinct Fine Specificities of Anti-Citrullinated Peptide Antibodies With Elevated Immune Responses to Prevotella intermedia in a Subgroup of Patients With Rheumatoid Arthritis and Periodontitis.

Anja Schwenzer, Anne-Marie Quirke, Anna M Marzeda, Alicia Wong, Anna B Montgomery, Harlan R Sayles, Sigrun Eick, Katarzyna Gawron, Maria Chomyszyn-Gajewska, Katarzyna Łazarz-Bartyzel and 8 more

Open access · hybridAbstract read
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 4 countries.

Anja SchwenzerUniversity of Oxford, Oxford, UK.
Anne-Marie QuirkeUniversity of Oxford, Oxford, UK.
Anna M MarzedaUniversity of Oxford, Oxford, UK, and Jagiellonian University, Krakow, Poland.
Alicia WongJagiellonian University, Krakow, Poland.
Anna B MontgomeryUniversity of Oxford, Oxford, UK.
Harlan R SaylesUniversity of Nebraska Medical Center, Omaha.
Sigrun EickUniversity of Bern, Bern, Switzerland.
Katarzyna GawronJagiellonian University, Krakow, Poland.
Maria Chomyszyn-GajewskaJagiellonian University, Krakow, Poland.
Katarzyna Łazarz-BartyzelJagiellonian University, Krakow, Poland.
Simon DavisUniversity of Oxford, Oxford, UK.
Jan PotempaJagiellonian University, Krakow, Poland, and University of Louisville, Louisville, Kentucky.
Benedikt M KesslerUniversity of Oxford, Oxford, UK.
Roman FischerUniversity of Oxford, Oxford, UK.
Patrick J VenablesUniversity of Oxford, Oxford, UK.
Jeffrey B PayneUniversity of Nebraska Medical Center, Lincoln.
Ted R MikulsUniversity of Nebraska Medical Center and Nebraska-Western Iowa Health Care System, Omaha.
Kim S MidwoodUniversity of Oxford, Oxford, UK.
University of Oxford · GBJagiellonian University · PLUniversity of Nebraska Medical Center · USUniversity of Bern · CHUniversity of Louisville · US

Funding

Tracking and Evaluation CoreU54GM115458 · NIGMS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI HOLSTEIN, SARAH A · 2016 to 2025
$42.8M
Bacterial peptidylarginine deiminase, a link between gums and joint diseaseR01DE022597 · NIDCR · UNIVERSITY OF LOUISVILLE · PI POTEMPA, JAN S · 2013 to 2023
$3.7M
LOW-DOSE DOXYCYCLINE EFFECTS ON OSTEOPENIC BONE LOSSR01DE012872 · NIDCR · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI PAYNE, JEFFREY BRUCE · 2001 to 2007
$3.0M
Arthritis Research UK 20003CSRD VA I01 CX000896NIDCR NIH HHS R01 DE012872NIDCR NIH HHS R01 DE022597NIGMS NIH HHS U54 GM115458Versus Arthritis 20003
6 · The paper itself

Abstract

objectiveIn addition to the long-established link with smoking, periodontitis (PD) is a risk factor for rheumatoid arthritis (RA). This study was undertaken to elucidate the mechanism by which PD could induce antibodies to citrullinated peptides (ACPAs), by examining the antibody response to a novel citrullinated peptide of cytokeratin 13 (CK-13) identified in gingival crevicular fluid (GCF), and comparing the response to 4 other citrullinated peptides in patients with RA who were well-characterized for PD and smoking.

methodsThe citrullinomes of GCF and periodontal tissue from patients with PD were mapped by mass spectrometry. ACPAs of CK13 (cCK13), tenascin-C (cTNC5), vimentin (cVIM), α-enolase (CEP-1), and fibrinogen β (cFIBβ) were examined by enzyme-linked immunosorbent assay in patients with RA (n = 287) and patients with osteoarthritis (n = 330), and cross-reactivity was assessed by inhibition assays.

resultsA novel citrullinated peptide cCK13-1 (

conclusionThis study identifies 2 groups of ACPA fine specificities associated with different RA risk factors. One is predominantly linked to smoking and shared epitope, and the other links anti-cTNC5 and cCK13-1 to infection with the periodontal pathogen P intermedia.

Indexed as

Anti-Citrullinated Protein AntibodiesArthritis, RheumatoidBiomarkers, TumorDNA-Binding ProteinsEnzyme-Linked Immunosorbent AssayFemaleFibrinogenGingival Crevicular FluidHumansImmunity, ActiveKeratin-13MaleMass SpectrometryOsteoarthritisPeptides, CyclicPeriodontitisAnti-Citrullinated Protein AntibodiesBiomarkers, Tumorcyclic citrullinated peptideDNA-Binding ProteinsENO1 protein, humanFGB protein, humanFibrinogenKeratin-13Peptides, CyclicPhosphopyruvate HydrataseTenascinTumor Suppressor ProteinsVimentin

Identifiers

PMID29084415
PMCPMC5711558
OpenAlexW2765948572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.